Cannabinoids In Late-onset Alzheimer's Disease

Alzheimer's Disease Cognitive Function (Decreasing)

Key Findings

Several in vitro and in vivo studies have demonstrated that cannabinoids can reduce oxidative stress, neuroinflammation, and the formation of amyloid plaques and neurofibrillary tangles, the key hallmarks of late-onset Alzheimer's disease. In addition, in population-based studies, cannabinoids reduced dementia-related symptoms (e.g., behavioral disturbances).

Information and Links


Link: Cannabinoids In Late-onset Alzheimer's Disease

Year: 2015

DOI: 10.1002/cpt.117


Ratings

(How Ratings Work)

Alzheimer's Disease — 3


Likely probability of the efficacy of cannabis for treatment of Alzheimer's Disease according to the results found in this study.

Cognitive Function (Decreasing) — 3


Likely probability of the efficacy of cannabis for treatment of Cognitive Function (Decreasing) according to the results found in this study.

Drugs Used

Cannabinoids